Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion.

Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion. Abstract Text:

Eileen M Finnegan,Aslihan Turhan,David E Golan,Gilda A Barabino,

Recent in vivo studies suggest that adherent leukocytes bind RBCs and contribute to the microvascular pathology that characterizes sickle cell disease (SCD). A parallel-plate flow assay was used: to investigate the capture of RBCs by adherent neutrophils, monocytes, and T-lymphocytes; to examine whether RBC capture is elevated in patients with SCD; and to determine whether hydroxyurea (HU) therapy affects these interactions. Four measures of cell-cell adhesion were used: adhesion of leukocytes to TNF-alpha-treated human umbilical vein endothelial cells (HUVECs), percent of adherent leukocytes that captured RBCs, number of RBCs captured per interacting leukocyte, and duration of RBC capture. Leukocyte subpopulations from sickle patients were more adherent to activated ECs and captured more RBCs per interacting leukocyte than the corresponding subpopulations from healthy controls. While HU did not affect leukocyte adhesion to activated ECs, it reduced the proportion of adherent leukocytes that captured RBCs, as well as the number of RBCs captured per neutrophil. T-lymphocytes demonstrated elevated adhesion in all measures, and may be the leukocyte subpopulation whose behavior is most altered in SCD. Our findings suggest that neutrophils, monocytes, and T-lymphocytes could all be involved in adhesive interactions with autologous RBCs in patients with SCD.

Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion. Publishing Authors By Initials

EM Finnegan,A Turhan,DE Golan,GA Barabino,

For similar cardiovascular diseases: vascular diseases research abstracts see: cardiovascular diseases: vascular diseases research

PUBMED ID PMID:

MEDLINE DATE:

Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: American journal of hematology

VOLUME: 82

Page Numbers: 266-75

Journal Abbreviation: Am. J. Hematol.

ISSN: 0361-8609

DAY: 3

MONTH: Apr

YEAR: 2007

Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7610369

Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion. Keywords Mesh Terms:

KEYWORDS: Vascular Diseases

MESH TERMS: physiopathology

Chemical & Substance for Abstract: Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion. Information

Substance Name: Hydroxyurea

Registry Number: 127-07-1

Grant and Affiliation Information for Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion.

AFFILIATION: Department of Chemical Engineering, Northeastern University, Boston, Massachusetts 02115, USA.

Country: United States

AGENCY: United States NHLBI

GRANT: HL-71631

ACRONYM: HL

MEDLINETA: Am J Hematol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion Related Publications

• Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion.
• CT and MRI of paediatric Crohn disease.
• Enhancing cell seeding of scaffolds in tissue engineering through manipulation of hydrodynamic parameters.
• New test to quantify lipid layer behavior in healthy subjects and patients with keratoconjunctivitis sicca.